logo

INVA

Innoviva·NASDAQ
--
--(--)
--
--(--)
5.12 / 10
Netural

Innoviva's fundamentals score 5.1/10, indicating moderate financial health. Strengths include an 11.17% year-over-year revenue growth and a Days Sales Outstanding of 23 days, both placing the company in higher performance quartiles. However, a PB-ROE deficit of -0.2445 and an Interest Coverage Ratio of 15.48 suggest areas for improvement. Overall, the balance of factors results in a neutral fundamental rating, with performance metrics showing room for growth but no critical red flags.

Fundamental(5.12)SentimentTechnical

Analysis Checks(9/10)

Revenue-MV
Value-0.38
Score3/3
Weight15.86%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value11.17
Score2/3
Weight1.35%
1M Return1.11%
Days sales outstanding
Value23.00
Score2/3
Weight1.38%
1M Return1.10%
Profit-MV
Value1.41
Score2/3
Weight12.65%
1M Return8.45%
Net income-Revenue
Value1.67
Score2/3
Weight12.66%
1M Return8.45%
PB-ROE
Value-0.24
Score1/3
Weight15.40%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.27%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value11.17
Score2/3
Weight0.52%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight23.45%
1M Return13.15%
Cash-MV
Value0.30
Score3/3
Weight17.99%
1M Return9.67%
Is INVA undervalued or overvalued?
  • INVA scores 5.12/10 on fundamentals and holds a Fair valuation at present. Backed by its 12.58% ROE, 32.78% net margin, 35.55 P/E ratio, 1.36 P/B ratio, and 95.05% earnings growth, these metrics solidify its Netural investment rating.